Amyotrophic lateral sclerosis and cancer: A register-based study in Sweden

References

• Tabares-Seisdedos R, Dumont N, Baudot A, Valderas JM, Climent J, Valencia A, et al. No paradox, no progress: inverse cancer comorbidity in people with other complex diseases. Lancet Oncol. 2011;12:604–8.
   PubMed Web of Science ®Google Scholar
• Plun-Favreau H, Lewis PA, Hardy J, Martins LM, Wood NW. Cancer and neurodegeneration: between the devil and the deep blue sea. PLoS Genet. 2010;6:1001257.
   PubMed Web of Science ®Google Scholar
• Bajaj A, Driver JA, Schernhammer ES. Parkinson’s disease and cancer risk: a systematic review and meta-analysis. Cancer Causes Control. 2010;21:697–707.
   PubMed Web of Science ®Google Scholar
• Liu R, Gao X, Lu Y, Chen H. Meta-analysis of the relationship between Parkinson’s disease and melanoma. Neurology. 2011;76:2002–9.
   PubMed Web of Science ®Google Scholar
• Driver JA, Beiser A, Au R, Kreger BE, Splansky GL, Kurth T, et al. Inverse association between cancer and Alzheimer’s disease: results from the Framingham Heart Study. Br Med J. 2012;344:1442.
   PubMedGoogle Scholar
• Elbaz A, Peterson BJ, Bower JH, Yang P, Maraganore DM, McDonnell SK, et al. Risk of cancer after the diagnosis of Parkinson’s disease: a historical cohort study. Mov Disord. 2005;20:719–25.
   PubMed Web of Science ®Google Scholar
• Lo RY, Tanner CM, van den Eeden SK, Albers KB, Leimpeter AD, Nelson LM. Comorbid cancer in Parkinson’s disease. Mov Disord. 2010;25:1809–17.
   PubMed Web of Science ®Google Scholar
• Brain L, Croft PB, Wilkinson M. Motor neuron disease as a manifestation of neoplasm (with a note on the course of classical motor neuron disease). Brain. 1965;88:479–500.
   PubMed Web of Science ®Google Scholar
• Mitchell DM, Olczak SA. Remission of a syndrome indistinguishable from motor neuron disease after resection of bronchial carcinoma. Br Med J. 1979;2:176–7.
   PubMed Web of Science ®Google Scholar
• Sadot E, Carluer L, Corcia P, Delozier Y, Levy C, Viader F. Breast cancer and motor neuron disease: clinical study of seven cases. Amyotroph Lateral Scler. 2007;8:288–91.
   PubMed Web of Science ®Google Scholar
• Chio A, Brignolio F, Meineri P, Rosso MG, Tribolo A, Schiffer D. Motor neuron disease and malignancies: results of a population based study. J Neurol. 1988;235:374–5.
   PubMed Web of Science ®Google Scholar
• Freedman DM, Travis LB, Gridley G, Kuncl RW. Amyotrophic lateral sclerosis mortality in 1.9 million US cancer survivors. Neuroepidemiology. 2005;25:176–80.
   PubMed Web of Science ®Google Scholar
• Fois AF, Wotton CJ, Yeates D, Turner MR, Goldacre MJ. Cancer in patients with motor neuron disease, multiple sclerosis and Parkinson’s disease: record linkage studies. J Neurol Neurosurg Psychiatry. 2010;81:215–21.
   PubMed Web of Science ®Google Scholar
• Freedman DM, Curtis RE, Daugherty SE, Goedert JJ, Kuncl RW, Tucker MA. The association between cancer and amyotrophic lateral sclerosis. Cancer Causes Control. 2013;24:55–60.
   PubMed Web of Science ®Google Scholar
• Baade PD, Fritschi L, Freedman DM. Mortality due to amyotrophic lateral sclerosis and Parkinson’s disease among melanoma patients. Neuroepidemiology. 2007;28:16–20.
   PubMed Web of Science ®Google Scholar
• Fang F, Chen H, Wirdefeldt K, Ronnevi LO, Al-Chalabi A, Peters TL, et al. Infection of the central nervous system, sepsis and amyotrophic lateral sclerosis. PLoS One. 2011;6:29749.
   Web of Science ®Google Scholar
• Richardson DB. An incidence density sampling programme for nested case-control analyses. Occup Environ Med. 2004;61:59.
   PubMed Web of Science ®Google Scholar
• Barlow L, Westergren K, Holmberg L, Talback M. The completeness of the Swedish Cancer Register: a sample survey for year 1998. Acta Oncol. 2009;48:27–33.
   PubMed Web of Science ®Google Scholar
• Armon C. Smoking may be considered an established risk factor for sporadic ALS. Neurology. 2009;73:1693–8.
   PubMed Web of Science ®Google Scholar
• Huncharek M, Haddock KS, Reid R, Kupelnick B. Smoking as a risk factor for prostate cancer: a meta-analysis of 24 prospective cohort studies. Am J Public Health. 2010;100: 693–701.
   PubMed Web of Science ®Google Scholar
• Secretan B, Straif K, Baan R, Grosse Y, El Ghissassi F, Bouvard V, et al. A review of human carcinogens − Part E: tobacco, areca nut, alcohol, coal smoke, and salted fish. Lancet Oncol. 2009;10:1033–4.
   PubMed Web of Science ®Google Scholar
• Gooley TA, Leisenring W, Crowley J, Storer BE. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med. 1999;18:695–706.
   PubMed Web of Science ®Google Scholar
• Sharp L, Vernino S. Paraneoplastic neuromuscular disorders. Muscle Nerve. 2012;46:839–40.
   PubMed Web of Science ®Google Scholar
• Forsyth PA, Dalmau J, Graus F, Cwik V, Rosenblum MK, Posner JB. Motor neuron syndromes in cancer patients. Ann Neurol. 1997;41:722–30.
   PubMed Web of Science ®Google Scholar
• Driver JA, Kurth T, Buring JE, Gaziano JM, Logroscino G. Prospective case-control study of non-fatal cancer preceding the diagnosis of Parkinson’s disease. Cancer Causes Control. 2007;18:705–11.
   PubMed Web of Science ®Google Scholar
• Driver JA, Logroscino G, Buring JE, Gaziano JM, Kurth T. A prospective cohort study of cancer incidence following the diagnosis of Parkinson’s disease. Cancer Epidemiol Biomarkers Prev. 2007;16:1260–5.
   PubMed Web of Science ®Google Scholar